European Heart Journal Advance Access originally published online on January 21, 2008
European Heart Journal 2008 29(4):480-489; doi:10.1093/eurheartj/ehm617
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial
1 Division of Cardiology, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland
2 University Hospital Wuerzburg, Wuerzburg, Germany
3 VU University Medical Center, Amsterdam, The Netherlands
4 Clinical Physiology Institute, Pisa, Italy
5 Charité, Berlin, Germany
6 University Hospital Uppsala, Uppsala, Sweden
7 Kerckhoff Clinics, Bad Nauheim, Germany
8 St Olaf University Hospital, Trondheim, Norway
9 St Lukes Episcopal Hospital, Texas Heart Institute, Houston, TX, USA
10 GE Healthcare Buchler GmbH & Co. KG, Munich, Germany
Received 22 April 2007; revised 11 November 2007; accepted 13 December 2007; online publish-ahead-of-print 21 January 2008.
* Corresponding author. Tel: +41 44 255 38 71, Fax: +41 44 255 44 01, Email: juerg.schwitter{at}usz.ch
See page 434 for the editorial comment on this article (doi:10.1093/eurheartj/ehn030)
Aims: To determine in a multicentre, multivendor trial the diagnostic performance for perfusion-cardiac magnetic resonance (perfusion-CMR) in comparison with coronary X-ray angiography (CXA) and single-photon emission computed tomography (SPECT).
Methods and results: Of 241 eligible patients from 18 centres, 234 were randomly dosed with 0.01, 0.025, 0.05, 0.075, or 0.1 mmol/kg Gd-DTPA-BMA (OmniscanTM, GE-Healthcare) per stress (0.42 mg/kg adenosine) and rest perfusion study. Coronary artery disease (CAD) was defined as diameter stenosis
50% on quantitative CXA. Five CMR and eight SPECT studies (of 225 complete studies) were excluded from analyses due to inadequate quality (three blinded readers scored per modality). The comparison of CMR vs. SPECT was based on receiver operating characteristic (ROC) analysis. Perfusion-CMR at the optimal CM dose (0.1 mmol/kg) had similar performance as SPECT, if only the SPECT studies of the 42 patients with this dose were considered [area under ROC curve (AUC): 0.86 ± 0.06 vs. 0.75 ± 0.09 for SPECT, P = 0.12]; however, diagnostic performance of perfusion-CMR was better vs. the entire SPECT population (AUC: 0.67 ± 0.05, n = 212, P = 0.013).
Conclusions: In this multicentre, multivendor trial, ROC analyses suggest perfusion-CMR as a valuable alternative to SPECT for CAD detection showing equal performance in the head-to-head comparison. Comparing perfusion-CMR with the entire SPECT population suggests CMR superiority over SPECT, which warrants further evaluation in larger trials.
Key Words: Magnetic resonance imaging Single-photon emission computed tomography Coronary artery disease Contrast medium Quantitative X-ray coronary angiography Myocardial perfusion
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- MR perfusion imaging. What will be its impact for detection of coronary disease in the future?
- Bernhard L. Gerber
EHJ 2008 29: 434-435.[Extract] [FREE Full Text]
This article has been cited by other articles:
![]() |
P. G. Camici and O. E. Rimoldi The Clinical Value of Myocardial Blood Flow Measurement J. Nucl. Med., July 1, 2009; 50(7): 1076 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Achenbach, V. Dilsizian, C. M. Kramer, and W. A. Zoghbi The Year in Coronary Artery Disease J. Am. Coll. Cardiol. Img., June 1, 2009; 2(6): 774 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nagel, J. A.C. Lima, R. T. George, and C. M. Kramer Newer methods for noninvasive assessment of myocardial perfusion cardiac magnetic resonance or cardiac computed tomography? J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 656 - 660. [Full Text] [PDF] |
||||
![]() |
A. S. Flett, M. A. Westwood, L. C. Davies, A. Mathur, and J. C. Moon The Prognostic Implications of Cardiovascular Magnetic Resonance Circ Cardiovasc Imaging, May 1, 2009; 2(3): 243 - 250. [Full Text] [PDF] |
||||
![]() |
M. Y. Desai and S. D. Flamm End of the Road for Delayed Hyperenhancement Cardiac Magnetic Resonance? J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 421 - 423. [Full Text] [PDF] |
||||
![]() |
C. Doesch, A. Seeger, J. Doering, C. Herdeg, C. Burgstahler, C. D. Claussen, M. Gawaz, S. Miller, and A. E. May Risk Stratification by Adenosine Stress Cardiac Magnetic Resonance in Patients With Coronary Artery Stenoses of Intermediate Angiographic Severity J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 424 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nagel Taking the Last Hurdles: Magnetic Resonance Myocardial Perfusion Imaging J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 434 - 436. [Full Text] [PDF] |
||||
![]() |
C. Klein, E. Nagel, R. Gebker, S. Kelle, B. Schnackenburg, K. Graf, S. Dreysse, and E. Fleck Magnetic Resonance Adenosine Perfusion Imaging in Patients After Coronary Artery Bypass Graft Surgery J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 437 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Alpendurada, J Wong, and D J Pennell Practical applications of cardiovascular magnetic resonance Heart Asia, March 31, 2009; 2009(3): 16 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lockie, E. Nagel, S. Redwood, and S. Plein Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes Circulation, March 31, 2009; 119(12): 1671 - 1681. [Full Text] [PDF] |
||||
![]() |
R. Y. Kwong Imaging the Physiology of the Ischemic Cascade: Are 2 Tools Better Than 1? Circ Cardiovasc Imaging, September 1, 2008; 1(2): 92 - 93. [Full Text] [PDF] |
||||
![]() |
M. G. Friedrich Tissue characterization of acute myocardial infarction and myocarditis by cardiac magnetic resonance. J. Am. Coll. Cardiol. Img., September 1, 2008; 1(5): 652 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schwitter Extending the Frontiers of Cardiac Magnetic Resonance Circulation, July 8, 2008; 118(2): 109 - 112. [Full Text] [PDF] |
||||
![]() |
B. L. Gerber MR perfusion imaging. What will be its impact for detection of coronary disease in the future? Eur. Heart J., February 2, 2008; 29(4): 434 - 435. [Full Text] [PDF] |
||||





